Exacerbation of neonatal hemolysis and impaired renal iron handling in heme oxygenase 1-deficient mice by Bednarz, Aleksandra et al.
International Journal of 
Molecular Sciences
Article
Exacerbation of Neonatal Hemolysis and Impaired 
Renal Iron Handling in Heme Oxygenase 
1-Deficient Mice
Aleksandra Bednarz 1, Paweł Lipiftski 2, Rafał R. Starzyftski 2, Mateusz Tomczyk 3,
Izabela Kraszewska 3, Sylwia Herman 1, Kacper K ow alski1, Ewelina Gruca 1, Aneta Joftczy 2, 
Rafał Mazgaj 2 , Mateusz Szudzik 2, Zenon Rajfur 4, Zbigniew Baster 4 , Alicja Józkowicz 3 and 
Małgorzata Lenartowicz k*
1 Department of Genetics and Evolution, Institute of Zoology and Biomedical Research,
Jagiellonian University, Gronostajowa 9, 30-387 Kraków, Poland; a.j.bednarz@doctoral.uj.edu.pl (A.B.); 
sylwiaherman@op.pl (S.H.); kacper1.kowalski@student.uj.edu.pl (K.K.); ewelinagruca96@gmail.com (E.G.)
2 Department of Molecular Biology, Institute of Genetics and Animal Biotechnology,
Polish Academy of Sciences, Jastrzebiec, 05-552 Magdalenka, Poland; p.lipinski@igbzpan.pl (P.L.); 
r.starzynski@igbzpan.pl (R.R.S.); a.jonczy@igbzpan.pl (A.J.); r.mazgaj@igbzpan.pl (R.M.); 
m.szudzik@igbzpan.pl (M.S.)
3 Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology,
Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland; tomczyk.mateusz@gmail.com (M.T.); 
izabela.kraszewska@doctoral.uj.edu.pl (I.K.); alicja.jozkowicz@uj.edu.pl (A.J.)
4 Department of Molecular and Interfacial Biophysics, Faculty of Physics,
Astronomy and Applied Computer Science, Jagiellonian University, Łojasiewicza 11, 30-348 Kraków, 
Poland; zenon.rajfur@uj.edu.pl (Z.R.); zbigniew.baster@doctoral.uj.edu.pl (Z.B.)
* Correspondence: malgorzata.lenartowicz@uj.edu.pl
© check for updates
Abstract: In most mammals, neonatal intravascular hemolysis is a benign and moderate disorder that 
usually does not lead to anemia. During the neonatal period, kidneys play a key role in detoxification 
and recirculation of iron species released from red blood cells (RBC) and filtered out by glomeruli to the 
primary urine. Activity of heme oxygenase 1 (HO1), a heme-degrading enzyme localized in epithelial 
cells of proximal tubules, seems to be of critical importance for both processes. We show that, in HO1 
knockout mouse newborns, hemolysis was prolonged despite a transient state and exacerbated, which 
led to temporal deterioration of RBC status. In neonates lacking HO1, functioning of renal molecular 
machinery responsible for iron reabsorption from the primary urine (megalin/cubilin complex) and 
its transfer to the blood (ferroportin) was either shifted in time or impaired, respectively. Those 
abnormalities resulted in iron loss from the body (excreted in urine) and in iron retention in the renal 
epithelium. We postulate that, as a consequence of these abnormalities, a tight systemic iron balance 
of HO1 knockout neonates may be temporarily affected.
Keywords: iron; heme; heme oxygenase 1; H m oxl gene; neonatal hemolysis; renal iron handling
1. Introduction
Heme oxygenase 1 (HO1, coded by the H m oxl gene) is an inducible, stress-responsive,
multifunctional enzyme playing an important role in inflammation and iron homeostasis. It catabolizes 
free heme, an iron protoporphyrin (IX), into equimolar amounts of ferrous iron (Fe2+), carbon monoxide 
(CO), and biliverdin [1]. Heme is an essential protein cofactor and signaling molecule [2]; however, 
on the other hand, it can exert cytotoxic effects via lipid peroxidation, protein cross-linking, and DNA
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damage. Therefore, intracellular heme concentration in so-called labile heme pools, available for 
trafficking within the cell, should be strictly regulated [3]. HO1 by degrading heme contributes to heme 
homeostasis and to the protection against free heme-induced toxicity. This latter function requires the 
co-expression of H-ferritin, which, by sequestering ferrous iron released from the protoporphyrin IX 
ring, neutralizes their pro-oxidant effects [4]. Importantly, in macrophages, which ingest senescent 
red blood cells, hemoglobin-derived heme is rapidly degraded by means of the catabolic activity of 
HO1, and then iron extracted from heme is exported by ferroportin, a membrane-bound molecule, 
into the circulation. Iron is transported in the blood in the complex with transferrin to the bone marrow 
for sustaining physiological erythropoiesis [5]. This pathway of heme iron recycling represents the 
main physiological route of iron egress in the body and, therefore, HO1 is a key enzyme in systemic 
iron turnover.
In mice, HO1 deficiency results in serious perturbations in iron reutilization [6- 9], which is 
directly associated with the inability of erythrophagocytosing macrophages to catabolize heme 
and their progressive loss during the lifespan [7,9]. HO1-deficient mice progressively developed 
intravascular hemolysis with age [6- 8]. Hemolysis has also been diagnosed in two cases of human HO1 
deficiency [10,11]. Hemolysis is a pathological condition, upon which a large amount of hemoglobin 
and/or heme is released into the plasma from damaged red blood cells. Together with haptoglobin and 
hemopexin (hemoglobin- and heme-binding plasmatic proteins, respectively), HO1 is as an effective 
protective agent against vascular injury caused by exogenous heme, reported in hemolytic disorders 
such as sickle-cell anemia [12].
The enhanced susceptibility of neonatal erythrocytes to increased oxidative stress is very likely 
the main reason of moderate intravascular hemolysis, which is a common, physiological condition 
in newborns. Interestingly, the course of neonatal hemolysis runs in parallel with developmentally 
impaired iron handling by liver macrophages [13]. Keeping all proportions, these phenomena are 
reminiscent of hemolytic events and macrophage dysfunction in HO1-deficient mice. We have recently 
demonstrated that, in mouse neonates showing clear symptoms of hemolysis, the kidney is the primary 
organ involved in heme uptake and catabolism and, thus, contributes to its detoxification, as well as to 
heme-derived iron recirculation from the primary urine to the blood [13]. Moreover, we have shown 
that, apart from heme and iron transporters, HO1 is exclusively expressed in the renal cortex and plays 
a pivotal role in these processes. Indeed, there is large evidence from human and animal studies that, 
in intravascular hemolytic disorders, kidneys and renal HO1 are involved in handling iron entering 
the circulation and then filtered out by glomeruli to the primary urine [14].
In this study, we explored the role of HO1 in renal iron homeostasis under conditions of neonatal 
hemolysis, using mice with the knockout of Hmoxl gene (Hmoxl--). Because Hmox1~-~ mice during the 
neonatal period were not characterized in terms of changes in systemic iron metabolism, we addressed 
this issue with a special emphasis on renal iron. Our results showed that, in Hmox1~-~ neonates, 
hemolysis is extended and strongly aggravated compared to wild-type (W T) ones, which results in 
deepened hemolytic anemia. Similarly to WT mice, kidneys of Hmox1~-~ animals take over the task of 
iron handling during neonatal hemolysis; however, their function due to the lack of HO1 activity is 
impaired. In consequence, renal iron recycling is inefficient, causing substantial loss of iron with urine.
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2. Results
2.1. Increased Hemolysis and Decreased Red Blood Cell Status in H m oxl--- Mouse Neonates
Recently, we determined a time-course of hemolysis in outbred mouse pups during the neonatal 
period [13]. Here, we confirmed those results using C57BL/6 X FVB mouse neonates. Furthermore, 
we showed that pups lacking heme oxygenase 1, a heme-degrading enzyme, develop much more 
severe and longer lasting hemolysis (Figure 1). To compare the time-course and intensity of hemolysis 
in wild-type (WT, Hmox1+ +̂ ) and Hmox1- /-  (HO1 KO) mice, we first determined blood plasma levels 
of hemopexin (Hx), the high-affinity heme-binding plasma protein, disappearance of which from the 
plasma is well recognized as a hallmark of hemolysis [15]. We found that Hx was barely detectable 
in the plasma of only 3 day old W T mice, whereas, in HO1 KO animals, it almost disappeared 
from the plasma between days 3 and 7 after birth (Figure 1a,b). Higher efficiency of recovery from 
hemolysis in W T mice was reflected by gradually higher Hx concentration in the plasma compared 
with Hmox1- /-  animals, starting from days 5 and 9 postpartum, respectively. Differences in the 
time-course and the intensity of hemolysis between Hmox1+̂ + and Hmox1- /-  mice were also confirmed 
by the results showing that the lactate dehydrogenase 2 (LDH2) plasma concentration (a marker for 
intravascular hemolysis) was maintained at higher levels in Hmox1- /-  mice throughout the entire 
analyzed neonatal period (Figure 1c). As a consequence of exacerbated hemolysis, 5 day old Hmox1-/-  
pups showed significantly diminished values of most RBC indices such as hemoglobin concentration, 
hematocrit (HCT), mean corpuscular hemoglobin (MCH), and mean corpuscular volume (MCV) 
(Table 1). An increased MCH concentration (MCHC) value points to hemolysis as an etiological factor. 
Interestingly, in 11 day old knockouts, weakening hemolysis was accompanied by the overall recovery 
from the decline in RBC status, as RBC indices returned to normal values observed in age-matched 
WT mice.
Table 1. Red blood cell (RBC) indices of 5 and 11 day old C57BL X FvB wild genotype (WT) and 
heme oxygenase 1 (HO1) knockout (KO) mice. Values are expressed as the means ± SD, n =  13 for 5 
day old WT mice, n =  13 for 5 day old KO mice, n =  8 for 11 day old wild-type mice, and n =  8 for 
11 day old Hmox1 knockout mice. To compare differences in each blood parameter between wild-type 
(WT) and Hmox1 knockout (KO) groups at each time point, we used Student t-tests for datasets 
where distribution was normal and Mann-Whitney U tests where data distribution was not normal. 
Abbreviations: RBC—red blood cells, HGB—hemoglobin, HCT—hematocrit, MCV—mean corpuscular 
volume, MCH—mean corpuscular hemoglobin, MCHC—mean corpuscular hemoglobin concentration, 
RDW-CV—red cell distribution width coefficient of variation, ns—not significant; * p < 0.05, ** p < 0.01,
*** p <  0.001.
Blood Parameters
5 Day Old Mice 
WT KO P
11 Day Old Mice 
WT KO P
RBC (M/pL) 3.6 ± 0.56 3.26 ± 0.46 ns 6.34 ± 0.51 6.03 ± 0.31 ns
HGB (g/dL) 9.11 ± 1.17 7.79 ± 1.02 ** 11.15 ± 1.86 10.59 ± 0.49 ns
HCT (%) 30.48 ± 5.14 23.8 ± 3.16 *** 41.01 ± 2.78 37.51 ± 1.99 *
MCV (fL) 84.49 ± 3.50 73.09 ± 4.38 *** 64.63 ± 1.19 62.25 ± 2.12 *
MCH (pg) 25.39 ± 1.29 24.07 ± 1.55 * 17.5 ± 2.03 17.55 ± 0.53 ns
MCHC (g/dL) 30.02 ± 1.39 33.09 ± 1.55 *** 27.06 ± 3.24 28.19 ± 0.49 ns
RDW-CV (%) 21.54 ± 1.77 23.62 ± 2.36 ns 15.36 ± 1.46 17.03 ± 0.87 *
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Figure 1. Hemopexin (Hx) and lactate dehydrogenase 2 (LDH2) proteins are markers of intravascular 
hemolysis in the blood of wild-type and Hmoxl-deficient neonatal mice;, (a) Pcasma levels of hemopexin 
(Hx) were assessed by Western blotting;. The blots were reprobed with polyclonal anti-albumin antibody 
as a loading control. Results come foom thoee separate blots and relative; levels of proteins are rhown 
in the graph (b). Immunolabeled Hx and alloumm control bands were (quantified using a Molecular 
Imager and the relative levels of thr test proteins (means ± SID, n = 3 joes group) are p lotted in arRitrary 
units. To compare diffarences in plasma Hx levels betwean wild-type (WT) and heme ooygenase 1 
(HO1) knockout (I0©) groups at each time point, we used Student t-tests for all datasets; * p <  0. 05. 
(e) Lactate dehydrogenase 2 (LDH2. plasma lev els in the serum from all age) groups op wild-type and 
Hmox1~e~ mice analyzed by Western blotting (WB; representative blot, n =  3). WB PVDF membrane 
stained with Ponceau S was used as a protein loading. conhol. dpp—dayo pos^artum.
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2.2. Delay in Kidney Development and Renal Iron Loss in the Neonatal Hmox1 - Mice
The kidneys are the main site of hemoglobin clearance and degradation under conditions of 
severe hemolysis [16- 18]. The structural and functional maturity of the kidneys is indispensable 
for this process. In mice, in the first week of the postnatal life, nephrogenesis is still in progress, 
and approximately half of all nephrons is formed over days 2 -4  after birth [19,20]. To see whether 
the process of nephrogenesis runs correctly in Hmox1-/-  neonates, we performed histological analysis 
of the kidneys from 5 day old mice. In the kidneys of the 5 day old W T mice, we observed renal 
corpuscles, with clearly distinguished renal glomeruli and formed Bowman's space, located in the renal 
cortex among renal tubules (Figure 2a, arrows). However, in the renal cortex of 5 day old Hmox1-/-  
mice renal corpuscles with developed Bowman's space were barely detectable, although we were able 
to identify developed glomeruli (Figure 2a, double arrows). Moreover, we noticed that, in the kidneys 
of Hmox1-/-  mice, renal tubules were poorly developed in comparison with this part of the nephron in 
the kidneys of WT controls (Figure 2a indicated by double arrowheads and arrowheads, respectively). 
All these data indicate that the process of nephrogenesis is delayed in Hmox1- /-  pups. Interestingly, 
in 11 day old mice, the histological picture of the kidneys was very similar in both WT and Hmox1-/-  
animals (Figure 2b).
To see whether differences in the histological structure of the kidneys directly translate into 
differences in kidney functioning, we performed a comparative analysis of urine volume in WT and 
Hmox1- /-  neonates. The obtained results indicate that, in neonates from all investigated age groups, 
the urine volume was significantly higher in wild-type mice than in Hmox1-/-  animals (Figure 2c). 
This suggests that the glomerular filtration is affected in Hmox1- /-  neonates. We also checked the total 
iron content in the urine of 3-11 day old mice of both genotypes. Atomic absorption spectroscopy 
(AAS) analysis revealed that, in the urine of 3 and 5 day old Hmox1-/-  neonates, iron concentration 
was significantly higher than in WT controls (Figure 2d,e). Interestingly, there were no statistically 
significant differences in iron content in urine in the 7-11 day old WT and Hmox1-/~ mice (Figure 2d,e).
Figure 2. Cont.
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Age groups
Figure 2. Kidney structure and urine analyses. (a,b) Hematoxylin-eosin staining of kidney sections from 
5 and 11 day old (WT) and heme oxygenase 1 (HO1) knockout (KO) neonates; 20x magnification (upper 
panels) or 40x magnification (bottom panels). Scale bars correspond to 100 gm in 20x magnification and 
50 gm in 40x magnification. (c) Iron concentration measured by AAS (atomic absorption spectroscopy) 
in urine samples of the WT and KO neonates from all age groups: n = 6 for WT 3 dpp, n = 10 for WT 5 
dpp, n = 10 for WT 7 dpp, n = 5 for WT 9 dpp, on = 6 for WT 11 dpp, n = 5 for ICO 3 dpp, n = 9 for KO 
5 dpp, n = 5 for KO 7 dpp, n = 5 for KO 9 dpp, and n = 5 for KO 11 dpp. To compare differences in 
urine iron concentration between WT and KO groups at each time point, Student t-tests were used for 
all datasets. (d) Urine volume collected from urinary bladder of mice after dissection: n = 16 for WT 
3 dpp, n = 19 for WT 5 dpp, n = 8 for WT 7 dpp, n = 12 for WT 9 dpp, n = 14 for WT 11 dpp, n = 14 
for KO 3 dpp, n = 18 for KO 5 dpp, n = 7 for KO 7 dpp, n = 9 for KO 9 dpp, and n = 9 for KO 11 dpp.
To compare differences in collected urine volumes between WT and Hmoxl knockout (KO) groups at 
each time point, Student t-tests were used in 3 dpp, 5 dpp, 7 dpp, and 9 dpp age groups (where data 
distribution was normal) and a Mann-Whitney U test was used in the 11 dpp age group (where data 
distribution was not normal). (e) Iron content in urine collected from urinary bladder of mice after 
dissection: n = 10 for WT 3 dpp, n = 12 for WT 5 dpp, n = 9 for WT 7 dpp, n = 5 for WT 9 dpp, n = 6 for 
WT 11 dpp, n = 5 for KO 3 dpp, n = 9 for KO 5 dpp, n = 5 for KO 7 dpp, n = 5 for KO 9 dpp, and n = 5 
for KO 11 dpp. To compare differences in total urine iron content between WT and Hmoxl KO groups 
at each time point, we used Student t-tests in all age groups. Values are expressed as the means ± SD; * 
p < 0.05, ** p < 0.01, *** p < 0.001. dpp—days postpartum.
2.3. Temporal Shift in the Increased Expression o f  Megalin-Cubilin Protein Complex in the Renal Proximal 
Tubules ofH m ox1- -  Neonates
We previously showed that, in the kidneys of WT mouse neonates, the expression of megalin 
and cubilin, involved in hemoglobin clearance in the renal proximal tubules [16], was transiently 
(between days 3 and 7 after birth) increased in the apical membrane of the epithelial cells of the renal 
proximal tubules [13]. Here, immunofluorescent (IF) co-localization studies of megalin and cubilin 
showed that the increased m egalin-cubilin IF signal in the apical part of the cortical renal tubules in 
Hmox1-/-  neonates was shifted in time compared to control animals and fell on days 7-11 postpartum 
(Figure 3a,b). In contrast to 3 day old WT neonates, we did not detect any megalin-cubilin IF signal 
in the kidney of Hmox1-/-  age-mates (Figure 3b). Interestingly, in 5 day old knockouts, we observed 
megalin-cubilin IF signals pointing to their intracellular localization in epithelial cells of the cortical 
renal tubules (Figure 3b). ImageJ analysis of the intensity of megalin/cubilin complex IF signals in the
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kidney of mice of both genotypes presented in Figure 3c revealed that the intensity of the IF signal for 
co-localization of megalin and cubilin (megalin/cubilin complex) was significantly higher in 3 and 5 day 
old WT than in KO neonates. These results indicate that, in the kidneys of the 3 and 5 day old Hmox1-/-  
mice, reabsorption of hemoglobin from the primary urine was less effective than in wild-type neonates.
Figure 3. Localization of megalin-cubilin c omplex in renal proximal tubules in wild-type (WT) and 
heme oxygenase 1 (HfO1) knockout (KO) neonatal mice. (a) Immunofluorescence (IF) staining of 
megalin (red channel) and cubilin (green channel) in the kidneys of the 3, 5n 7, 9, and 11 day old WT 
mice, analyzed lby confocal microscopy. Both transporters have apical localization in the epithelial cells 
of cortical renal tubules. Cell nuclei were counterstained with DAPI (blue). Scale bars correspond to 
20 pm. (b) IF strining o f megalin (eed channel) a nd cubilin ( green channel) in the? kidney i o1 the 3,5, 7,9, 
and 11 day old KO m ice, analyz ed by confocal micro siopy. Both transporters a re absent from epithelial 
cells of cortical renal tubule s in 3 day old knockout mice; In 5 da y old mice, they exhibit cytoplasmic 
localization, and, starting from day 1  both transporters have apical localization in the cells. Cell nuclei 
were counterstained with DAPI (blue). Scale bars correspond to 20 pm. (c) Quantitative analysis 
of co-localized fluorescent signal from me galin-cubilin c omplex in renal cor ti cal tubules . The mean 
fluorescence signal associated with megalin and cubilin was measured on the whole renal cortex by 
ImageJ analysis and quantified manually as a mean gray value; the intensities (means ± SD) are plotted 
in arbitrary units (AU)i n = 10 for WT 3 dpp, n = 9 for WT 5 dpp, n = 11 for WT 7 dpp, n = 8 for WT 
9 dpp, n = 13 for WT 11 dpp, n = 6 for ICO 3 dpp, n = 8 for ICC) 5 dpp, — = .4  fore KO 7 dpp, n = 5 
for KO 9 dpp, and n = 9 for KO 11 dpp. To compare differences in mean gray value (fluorescence 
intensity) between WT and Hmox1 KO groups at each time point, Student t-tests were used in 3 dpp and 
11 dpp groups, and Mann-Whitney U tests were used in 5 dpp, 7 dpp, and 9 dpp groups. ** p < 0.01, 
*** p < 0.001. dpp—days postpartum.
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2.4. Unaffected Expression o f Heme-Responsive Gene 1 (HRG1), A Heme Importer, in the Kidneys o f  
Hmox1~°~ Neonates
In our previous study [13], we localized the HRG1 protein in apical/subapical regions of epithelial 
cells of the renal cortex in WT neonates, which suggested its participation in the uptake on free heme 
from primary urine under conchhon/ of neonatal hemolysis. He rx, we confirmed thie localization 
in the kidneys c f  both WT and Hmox1~W~ mice (Figure 4a). Importantly, we show that, despite the 
enhanced hemolysis in Hmox1-/o  neonates, expression of the Slc48a1 gone (encoding HRG1 protein) at 
both messenger RNA (mRNA; Fegura 4b) and protein (Figure 4c,d) levels remains unaltered compared 
to WT mrice throughout the entire experimental period.
Figure 4. Cont.
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Figure 4. Heme transporter heme-responsive gene 1 (HRG1) in renal tissue. (a) Immunofluorescence 
(IF) staining of HRG1 (red channel) in the kidneys of 3 and 11 day old wild-type (WT) and heme 
oxygenase 1 ( HO1) KO mice, analyzed by confocal mic roscopy. Cell nuclei were counterstained with 
DAPI (blue). Scale bars correspond to 20 pm. (b) RT-qPCR analysis of HRG1 (Slc48a1) messenger 
RNA (mRNA) levels in the kidneys of WT and KO mouse ne onates. 'lire gcaph pre sents relative HRG1 
transcript levels in arlfitrary units (means ± SID, n = 5 per aroup; Student t-te st, NS). (c) HRG1 protein in 
kidneRs as sessed b y Westere blotting. The blots ware reprobed wlch polyclonal anti-actin antiboey as a 
sample loa ding control . Results c ome from lour separate blots and relative levels of proteins are shown 
in the graph (d). Immunolabele d HRG1 and actin control band s were quantified using a Mole cular 
Imager, and the reSative levels of the tested proteins are plotted in arbitrary units (means ± SID, n = 4 
per group; Student t-test, NS). dpp—days gostpartum, NS—not significant.
2.5. Heme Oxygenase 2 (HOI) Deficiency Is Not Compensated fo r  by the Increased Heme Oxygenase 2 (HO2) 
Expression in the Kidneys o f H m oxl- -  Mice
In view of our previous results, HO1 located in the epithelial cells of proximal tubules is mainly 
responsible for the breakdown of heme taken up from the primary urine during neonatal hemolysis in 
outbred m(ce [13]. Here, we confirmed HO1 renal localization in C57BL/6 X FVB mouse neonates and 
showed no HO1 IF signal in H m oxl- -  animaln (Figure 5a). To investigate the possible compsnsative 
contribution of HO2 to heme degra dation in the absence oH HO 1, we asressed tine expression of Hmox2 
gene at the mRNA levrl (Figure 5b ) and localization of HO2 protein (Figure 5c) in the kidneys r f  
neonates of both genotypes. Firct, IF detection of HO2 in renal sections showed clearly that this protein 
is localized in the ephhelial cells of the renal tubules in 3 and H day old HO1 knockout mice (Figure 5c). 
Consistent with the) rscognized role of Hmox2 as a housekeeping gene, expreised at relatively constant 
rates independently or pathophysiological conditions, HO2 mRNA levels in the kidneys of Hmcx2-/- 
neonates did not differ significantly compared to control mice and were relative^ stable throughout the 
entire neonatal period (Figure 5b). Our resuhs suggest that, under ccnditions of exaserbated hemolysis 
in Hmox1-/-  neonates, the lack of HO1 activity is not compensated for by the increased expression of 
HO2 enzyme in the kidney.
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Figure 5. Heme oxygenase 1 (HO 1) and heme oxygenase 2 (HO2) expression in the kidneys of wild-type 
and Hmoxl-deficient neonatal mile. (a) Immunofluorescence (IF1) staining of HO1 (red ceannel) in the 
kidneys of 3 and 1 1 day? old wild-type (WT) aired Hmoxl knockout (ICO) neo natal mice , analyzed by 
confocal microscopy. Cell nuclei were counterstained with DAPI (blue). Scale bars correspond to 20 pm.
(b) RT-qPCR analysis of HO2 mRNA levels in the kidne ys of 'WT and KO mouse neonates ranging 
from 3-11 days old. The? graph presents relative HO2 transcript levels in arbitrary unity (me?ans ± SD, 
n = 5 per group; Student l-test, NS). (c) IF staining of HO2 (reed channel) in the kidneys of 3 and 11 day 
old WT and KOneenatal mice?, analyzed by confocal microscopy. Cell nuclei were counterstained with 
DAPI (blue). Scale bars correspond to 20 pm. dpp—days postpartum, NS—not significant.
2.6. Residual Ferroportin (Fpn) Expression and Increasrd Iron Status in the Kidneys o f H m oxl- -  Neonates
It is well established that Fpn, the so le identified cell iron exporter [21], is localioed to the 
basolateral membrane of the epithelial cells of proximal renal tubules whers it functions air a protein 
releasing ioon accumulated in the kidney into the circulation [8,22- 24]. We recently showed that, 
under conditions of neonatal moderate hemolysis, expression of Fpn protein progressively declined 
in renal proximal tubules, and this decrease matched grodual disappearance of hemolysis in WT 
mouse neonates between days 3 and 11 after lbirth [13]. To check localization and expression of Fpn in 
Hmox1-/-  neonates, we performed immunofluorescent (IF) detoction of Fpn in transverse renal sections 
of 3 and 11 day old mice of both genoiypes (Figure 6a), as well as time-course Western blot analysis of 
Fpn levels in renal membrane extracts obtained from neonates from 13 to S1 days of age (Figure 6b ). 
Microscopic analysis of IF staining indicated typical localization of Fpn in the basaf membrane of 
epithelial cells of proxima] renal tubules only? in 3 daty? ole0 W"! neonates and disappearance of the IF 
Fpn signal in 11 doy old mice, as reported recently] [13]. In contrast, we did not detect an IF Fpn signal 
in both 3 and 11 day old Hmox1-/-  neonates. The results of Western blotting showed a gradual decrease 
in Fpn protein level in WT neonates, which contrasted with barely detectable Fpn levels in Hmox1-/-  
animals throughout the entire neonatal period. There is a large body of evidence that decreased Fpn 
protein levels on the cellular membrane leads to excessive intracellular iron content [21]. Therefore, 
we examined iron accumulation in the kidney of 3 and 11 day old Hmox1+̂ + and Hmox1-/~ neonates 
via histochemical analysis, i.e., by staining the renal sections with Perls' Prussian blue. We found 
blue iron deposits in sections across the renal cortex of the kidney of 11 day old Hmox1-/~ knockout 
neonates (Figure 6c). Iron accumulation in the kidneys of the H m ox1-/ - mice also led to increased
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expression of the H-ferritin (H-Ft) gene (Figure 6d). On the other hand, there was no evidence of iron 
loading in the kidneys of 11 day old WT neonates. On the basis of our results, it seems that drastically 
downregulated Fpn in epithel ial cells of proximal tubules of neo nates is respo nsible for
impaired recirculation and detoxification of ironaccumulated in these cells.
Figure 6. Ferroportin (Fpn) protein levels and locaOization, iron depositionr and H-ferritin (HFt) gene 
expression ire kklneys of wildetyp e (WT) and heme oxygenase 1 (H 0 1) knockout (KO) mouse neonates. 
(a) Immunofluorescence (IF) staining erf Fpn (red channel) in the kidneys of 3 and 11 day old (WT) and 
KO neonatal mice, analyzed by ronfocal microscopy. Cell nucler were countersdained with DA PI (blue). 
Scale bars correspond to 20 pm. (b) Fpn protein levels in the kidneys of WT and KO mice from all age 
groups analyzed by Western blotting. WB PVDF membrane stained with Ponceau S was used as a 
protein loading control. (c) Histochemical analysis of iron loading in the kidneys of 5 and 11 day old 
WT and KO mouse neonates by Perl's Prussian Blue staining. Iron deposits were detected in renal 
cortex of 11 day old KO mice (visible as blue deposits), whereas, in kidneys from WT mice of the same 
age and 5 day old mice of both genotypes, iron deposits were absent. Renal tissue was counterstained 
with pararosaniline (pink) and the scale bar corresponds to 10 pm. (d) RT-qPCR analysis of H-Ft mRNA 
levels in the kidneys of WT and KO mouse neonates ranging from 3-11 days old. The graph presents 
relative H-Ft transcript levels in arbitrary units (means ± SD, n =  5 per group). We used Student 
t-tests for all datasets; * p <  0.05, ** p <  0.01, *** p <  0.001. dpp—days postpartum, MWM—molecular 
weight marker.
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2.7. Increased Hepcidin Expression in the Liver o f  3 Day Old Hm oxl -
Hepcidin is a small peptide hormone that orchestrates body iron fluxes, produced mainly by 
hepatocytes. Hepcidin binds to Fpn to induce its degradation, thus inhibiting iron release from 
exporting cells [21]. Its expression is controlled by iron levels (circulating and liver iron content), 
erythropoietic activity, and inflammatory cues [22]. To find o ut the reason why fe rroportin protein is 
barely detectable in the kidney of Hmoxl~^~ neonates, we examined hepcidin mRNA abundance in t tie 
liver vS 3 and 11 day old mice, comparipg the obtained resuhs with hepcidin dranscript levels in thn 
livers of age-matched control animals (Figure 7). We observed a strong, significant increane in hepcidin 
mRNA level in 3 day old HO1 onockouts compared to controls in the same age (Figure 7). We elso 
found that hepcidin mRNA expression in the liver of 11 day old neonates af both genotypes did not 
differ apd remained very low (Figuae 7). These results guggest thht increased hepcidin plays a roles in 
the negative regulotion oh renal Fpn in 3 day old H nemnates.
Figure 7. Hepcidin (Hamp) expression in the liver of wild-type (Wh) and heme oxygenase 1 (HO1) 
knockout (KO) mice. RT-qPCR analysis of hepcidin mRNA levels in ths livers of Wh and ICO) 3 and 
11 day old mouse neonateres. The graph presents relative hepcidin transcript levels in arbitrary units 
(means ± SD, n = 5 per group). To compare differences, we used Student t-test; * p <  0.05, ** p <  0.01. 
dpp—days postpartum.
3. Discussion
Dysregulation of systemic iron homeostasis in HO1 deficiency, reflected by defective iron recycling 
and redistribution of tis sues iron, wao intensivoly expl ored in a mouse mod el [6- 8] an d in 6- and 15 year 
old patients [10,11]. It is evident from animal studiet that abnormalities as sociated with HO1 deficienc° 
develop progre sswely with age [6,9,26] . To the best of o ur knowledge, t he 10 week old H m o mice 
are so far the youngest svrnals examined toward iron pathology diagnosed ao having no sgmptoms 
observed in older individuals [6]. Here, we examined for the first time chdnges in iron metabohsm in 
Hmgxl.-- -  mouse pups be tween days 3 and 11 a fte r birth. The main p rem ise for this invesfigafi on was 
the key role of renal HO1 in iron redistribution during neonatal physiological intravascular hemolysis 
in wild-type mice [13]. We found a strong aggravation and an entension in time or neonatal hnmolysis 
in Hmox1- ~ mice, indicated by hemolysis markers such as decreased hemopexin and increased lactate 
dehydrogenase levels in the blood plasma. Exacerbated hemolysis in mice resulted in the
deterioration of RBC status in 3 day old neonates at the borderline of anemia. This points to a crucial 
role of HO1 in preventing hemolysis and shows that hemolytic anemia reported previously only in 
adult H m oxl---  mice [6- 8] also temporarily affects neonates.
Kidney is an organ highly adapted to reabsorb both non-heme and heme iron filtered in the 
glomerulus to the primary urine and to recirculate it across epithelial cells of proximal tubules into 
the blood stream [14]. Under intravascular hemolysis conditions, such as chronic hereditary and
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acquired hemolytic anemias, kidneys participate in the management of iron released from disrupted 
erythrocytes to the blood plasma [27- 30]. It is clear that the structural and functional maturity of the 
kidneys is indispensable for this process. Meanwhile, histological analysis of the kidney of 5 day 
old HO1 KO mice revealed that the renal corpuscle, a structure within which filtration process takes 
place, composed of the glomerulus surrounded by double-walled epithelial Bowman's capsule, is not 
fully formed. This observation strongly suggests that, in KO mice, renal development is delayed 
in comparison with W T animals. It is known that vasculogenesis and angiogenesis contribute to 
the formation of glomeruli in the developing kidney [19]. Keeping in mind that HO1 facilitates 
angiogenesis through modulating expression of angiogenic factors [31], it is tempting to propose 
that the lack of HO1 activity can lead to the delay in glomeruli formation. Decreased volume of 
urine collected from Hmox1- /-  mice throughout the experimental period, as well as increased iron 
concentration in the urine falling for days with the greatest intensity of hemolysis, is a probable 
consequence of the developmental retardation of the morphological development of kidneys and 
functional renal insufficiency. Most importantly, increased total amount of iron excreted with urine was 
recorded just after the peak of hemolysis (day 5 after birth). This urinary loss of iron might contribute to 
worsening of a fragile systemic iron balance in knockout neonates. Therefore, a major question arises as 
to the efficiency of molecular mechanisms of renal iron handling in Hmox1- /-  neonates. Recently, in a 
time-course study, we explored the role of megalin-dependent, cubilin-mediated endocytic transport 
of iron from the primary urine by proximal tubules of epithelial cells during the neonatal hemolysis 
in wild-type mice [13]. The multi-ligand hetero-dimeric receptor complex megalin/cubilin present at 
the apical membrane of the tubular epithelium is responsible for the uptake of both hemoglobin and 
transferrin-bound iron [32]. Our present results show that the full expression of the complex in the 
renal proximal tubules of pups lacking HO1 is delayed few days compared to controls, i.e., it appears 
only in 7 day old Hmox1- /-  animals, while, in age-matched controls, it is already starting to decay. 
This time-shifted megalin-cubilin expression does not overlap with the hemolysis peak and probably 
explains why, in the absence of this complex in 5 day old Hmox1- /-  mice, iron is not reabsorbed by the 
renal epithelial cells and is excreted from the organism with urine.
To further assess the potential of epithelial cells of the renal cortex to scavenge heme iron from 
the primary urine during intensified neonatal hemolysis in Hmox1- /-  mice, we examined the heme 
transporter, HRG1 protein, (identified in the intestine of Caenorhabditis elegans [33]), in the kidney at 
extreme time-points of hemolysis development, i.e., on days 3 and 11 after birth. Surprisingly, we found 
in animals of both genotypes a similarly high and low level of the HRG1 protein at the beginning and 
at the end of hemolysis, respectively. Likewise, HRG1 protein showed the same localization in the 
proximal renal tubules in Hmox1- /-  and Hmox1+̂ + mice. It seems, therefore, that, upon exacerbated 
hemolysis in Hmox1- /-  neonates, HRG1 anchored in the apical membrane of epithelial cell in proximal 
tubules [13] is not upregulated, probably because free heme, a natural HRG1 ligand, is not a dominant 
heme iron compound appearing in the primary urine.
We recently provided evidence that HO1 is one of the most important players in renal iron handling 
under conditions of neonatal hemolysis [13]. In the absence of HO1 activity, the question always 
arises as to the potential compensation of this deficiency by HO2, a constitutively expressed enzyme 
that is involved in heme breakdown under physiological conditions [34]. Interestingly, recent studies 
indicated that young mice compared with aged animals (showing impairment in the inducibility of 
HO1) succeeded in the induction of HO2 in the kidney in response to hemoglobin [35]. However, here, 
we showed that, in the kidney of 3 and 11 day old Hmox1- /-  and control neonates, HO2 expression 
and distribution in the renal cortex and core were similar. Accordingly, in bone marrow-derived 
macrophages from adult HO1 KO mice, the expression of HO2 was not increased above the level 
detected in age-matched controls [7]. Tissue loading with non-heme iron is a real hallmark of HO1 
deficiency [6- 8]. Consistent with this is the accumulation of non-heme iron deposits in the kidney of 
11 day old Hmox1- /-  mice. The question as to how intracellular heme iron is converted to non-heme iron 
in the absence of HO1 has never been fully answered. Poss and Tonegawa have suggested, that apart
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from HO2, a major contributor to endogenous HO activity and, therefore, non-heme iron release from 
heme molecules under basal conditions, alternative nonspecific and less efficient enzymatic systems of 
heme degradation become functional [6].
On the basis of our results, we propose a scheme of renal iron handling in HO1 deficiency 
during the neonatal period. Under conditions of increased hemolysis in Hmox1-/-  mouse newborns, 
the reabsorption of iron (mainly in the form of hemoglobin) filtered in the glomerulus to the primary 
urine is impaired due to the absence of the megalin cublin complex on the apical membrane of the 
epithelial cells of renal proximal tubules. Then, as this complex appears (in 7 day old mice), hemoglobin 
is taken up by the renal epithelium. However, in the absence of HO1, the process of intracellular iron 
release from hemoglobin-derived heme molecules is slow, and detectable ferritin (Ft) iron deposits 
emerge only in 11 day old mice. It is well established that H and L subunits forming the molecule 
of ferritin, an iron storage protein that can accommodate up to 4500 atoms of iron [36], are mainly 
upregulated by non-heme iron via the IRP/IRE (iron regulatory protein/iron responsive element) 
post-transcriptional system [37] . Although we do not exclude such adjustment occurring in the 
Hmox1-/-  renal epithelium, it is worth noting that the level of H-ferritin mRNA was strongly elevated 
in Hmox1-/-  mice throughout the entire neonatal period. The H-Ft gene is known to be highly inducible 
by several environmental signals, including cytokine stimulation, stress signals, and a disease state [38] . 
Interestingly, it was reported that transcriptional regulation of the H-Ft gene is mediated by heme [39]. 
This regulation may involve heme-dependent stabilization of Nrf2 transcription factor, which in turn 
was demonstrated to induce H-Ft gene in response to xenobiotics [40] . We, therefore, suggest that 
an elevated labile heme pool [3] maintained in epithelial cells of Hmox1-/-  mice is responsible for 
the increase in H-Ft mRNA level. Undoubtedly, one of the main causes of iron retention in renal 
epithelial cells of Hmox1-/-  mice is the decreased level of ferroportin (Fpn) protein, the only known 
mammalian exporter of non-heme iron [41]. While, in control animals, Fpn gradually decreases from 
day 3 to day 11 after birth, in Hmox1-/-  neonates, it is barely detectable throughout the neonatal 
period. Initially (day 3 after birth), the low Fpn level may be due the high hepcidin expression in the 
liver of Hmox1-/-  mice, consistent with functioning of the hepcidin-ferroportin regulatory axis [42], 
which seems to be an overriding molecular mechanism that controls Fpn protein level. A  possible 
mechanism underlying upregulation of hepcidin may involve bone morphogenetic protein 6 (BMP6), 
a main activator of hepcidin [43], expressed predominantly in hepatic endothelial sinusoidal cells 
and modulated by iron fluctuations [44]. In this context, it is noteworthy that, of all sites in the body, 
the endothelium may be on the front line of exposure to heme and non-heme iron released from RBCs 
upon intravascular hemolysis [45]. This may impact endothelial iron-dependent toxicity but may also 
affect BMP6-depndent signaling.
In conclusion, to the best of our knowledge, findings of this study provide for the first time evidence 
of impaired iron handling in the kidney of Hmox1-/-  mice in response to exacerbated intravascular 
hemolysis during neonatal period. Dysregulation of iron-related genes in the kidneys results in the 
loss of iron from the body with urine secretion and in disturbed iron transfer from the epithelial cells 
of renal tubules into the blood circulation. Our results also indicate that the decreased RBC status of 
Hmox1-/-  neonates associated with intravascular hemolysis is a transient abnormality that bears no 
mechanistic connection to severe microcytic anemia observed in aged Hmox1-/-  mice [6- 8], resulting 
from reduced viability of erythrophagocytosing macrophages [7].
4. Materials and Methods
4.1. Mice
Male and female mice (C57BL/6 X FVB) homozygous for the nonfunctional Hmox1 allele (Hmox1- / - , 
HO1 knockout) and control mice (C57BL/6 X FVB, Hmox1+̂ +) were used in experiments. HO1 knockout 
mice were obtained by crossing heterozygous Hmox1+̂ ~ females and Hmox1-/-  males. Genotyping 
using DNA isolated from mice tails was performed by PCR analysis. We examined 3 ,5 , 7 ,9 , and 11 day
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old mice with the day of birth counted as day 1. Up to the day of sacrifice, all pups remained with 
their mothers. All animals were bred in animal facility of the Faculty of Biochemistry, Biophysics, 
and Biotechnology, Jagiellonian University in Krakow, under specific pathogen-free (SPF) conditions. 
Mice were maintained in individually ventilated cages, under controlled environmental conditions 
(12 h light/dark cycle, at approximately 23 °C). All animal procedures were in accordance with Guide 
for the Care and Use of Laboratory Animals (Directive 2010/63/EU of European Parliament) and 
approved by the First Local Ethical Committee on Animal Testing at the Jagiellonian University in 
Krakow (permission number: 136/2015, approval code: ZI/49/2015, approval date: 26.05.2015).
4.2. Sample Collection
Neonatal mice were anesthetized with 5% (v/v) isoflurane in air and then sacrificed by decapitation. 
Blood samples were taken from neck veins using heparinized tips and kept in heparin-coated tubes 
on wet ice for further processing. For plasma retrieval, samples were centrifuged at 800X g, 4 °C, 
for 10 min, frozen in liquid nitrogen, and stored at -8 0  °C for further analyses. Urine samples were 
taken directly from the urinary bladder, and the volumes of samples were measured using automatic 
pipette. Samples were frozen in liquid nitrogen and stored at -8 0  °C. Kidneys and livers were frozen 
immediately after the dissection and kept at -8 0  °C for further molecular analyses. Tissue samples for 
immunofluorescence analysis were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS). 
For the preparation of paraffin-embedded sections, kidneys were fixed in Bouin's solution for 24 h.
4.3. Measurement o f Red Blood Cell Indices
Blood for hematological analysis was collected in EDTA-coated tubes (Microvette 100, Sarstedt). 
The red blood cell count (RBC), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume 
(MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), 
and red cell distribution width coefficient of variation (RDW-CV) were determined using an automated 
hematology analyzer (Abacus Junior Vet 5; Diatron, Budapest, Hungary).
4.4. Western Blot Analysis
To determine plasma hemopexin (Hpx) and lactate dehydrogenase 2 (LDH2) levels, 10 pL samples 
of 25-fold diluted mouse blood plasma were resolved by electrophoresis on 10% SDS-PAGE gels. 
Heme-regulated gene 1 (Hrg1/Slc48a1) protein was detected in 20 pg of kidney membrane extracts 
(prepared as described previously [8]) following electrophoresis on 16% SDS-PAGE gel. Ferroportin 
(Fpn) protein was detected in 40 pg of kidney membrane extracts (prepared as described previously [8]) 
following electrophoresis on 10% SDS-PAGE gels. Electroblotting of the resolved proteins onto a 
PVDF membrane (Millipore, Burlington, MA, USA), where blocking and incubation with primary 
antibodies were performed as described previously [13]. The primary and secondary antibodies 
used for immunoblotting experiments are described in Table S1 (Supplementary Materials). For the 
quantitative analysis of protein content, reactive band intensities were quantified relative to those of 
albumin (plasma samples) or actin (kidney samples) by densitometric analysis using Quantity One 
software (Bio-Rad, Hercules, CA, USA).
4.5. Hematoxylin-Eosin Staining and Histological Analysis o f the Kidney Sections
Following fixation in Bouin's solution for 24 h, kidneys were stored in 70% ethanol before further 
preparation. The tissue was embedded in paraffin and 7 pm cross-sections were cut with a microtome 
(Reichert-Jung, Nussloch, Germany). The sections were stained with hematoxylin and eosin. Slides 
were examined by light microscopy (Olympus, type CH2, Hamburg, Germany).
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4.6. Measurement o f Iron Content in Urine
The level of iron in urine samples was measured by atomic absorption spectrophotometry (AAS). 
First, 20 pL of urine was diluted in 2 mL of boiling Suprapur-grade nitric acid (Merck, Darmstadt, 
Germany). After cooling to room temperature, each sample was suspended in 2 mL of deionized water. 
Reference material samples were prepared in a similar manner. The iron concentration was measured 
using the graphite furnace AAS technique (AAnalyst 800, Perkin-Elmer, Waltham, MA, USA). Three 
samples of pure nitric acid were used as blanks. In addition, three samples of a standard reference 
material, Fe mg/kg 197.94 ±  0.65, were used for normalization of the obtained data.
4.7. Immunofluorescence (IF) Analysis and Confocal Microscopy o f Kidney Sections
After laparotomy, mouse kidneys were immediately dissected and fixed in 4% paraformaldehyde 
(Sigma-Aldrich, Saint Louis, MO, USA) in phosphate-buffered saline (PBS) at 4 °C for 24 h. Following 
two 30m in washes in PBS, the tissues were successively soaked in 12.5% and 25% sucrose (Bioshop, 
Burlington, ON, Canada) for 2 h and 7 days, respectively, at 4 °C. Renal samples were then embedded in 
Cryomatrix medium (Thermo Scientific, Waltham, MA, USA), frozen in liquid nitrogen, and sectioned 
in 20 pm slices using a cryomicrotome (Shandon, UK). The sections were washed in PBS for 10m in 
and permeabilized by bathing in PBS/0.1% Triton X-100 (Sigma-Aldrich, Saint Louis, MO, USA) 
for 20 min. Nonspecific antibody binding was blocked by incubating the tissue sections in PBS/3% 
bovine serum albumin (BSA) (Bioshop, Burlington, ON, Canada) for 1.5 h. For protein detection, 
sections were incubated overnight at room temperature with primary antibodies diluted in PBS/3% 
BSA. As a negative control, some sections were incubated without primary antibody. The primary 
and fluorochrome-conjugated secondary antibodies used in IF analysis are described in Table S2 
(Supplementary Materials). Next, the sections were washed for 5 X 6 min with PBS/0.1% Triton 
X-100 and incubated for 1.5 h with secondary antibody diluted in PBS/3% BSA at room temperature. 
Finally, sections were washed for 10 min in PBS and mounted in Fluoroshield medium with DAPI 
(Sigma-Aldrich, Saint Louis, MO, USA). The presence of megalin and cubilin proteins in renal tissues 
was determined by double immunofluorescence localization. In order to distinguish the different 
proteins in experiment, the secondary antibodies were conjugated with different fluorochromes: Cy3 
for megalin and Alexa488 for cubilin. IF was analyzed with a Zeiss LSM 710 confocal microscope 
(Carl Zeiss, Oberkochen, Germany) using a 40X objective and Zeiss ZEN software (Carl Zeiss, 
Oberkochen, Germany).
4.8. ImageJ Analysis o f  Immunofluorescence (IF) Images
ImageJ analysis was performed to characterize immunofluorescent signal from megalin and 
cubilin. Samples were prepared and analyzed on confocal microscope as described previously [13]. 
ImageJ software (NIH, Bethesda, MD, USA) was used to measure mean fluorescence coming from both 
megalin and cubilin in the whole renal cortex on each photograph. The signal intensity was quantified 
to generate a mean gray value, i.e., the sum of gray values in the selected area divided by the number 
of pixels within that area.
4.9. Real-Time Quantitative PCR (RT-qPCR)
Total cellular RNA was extracted from livers and kidneys of experimental mice using an 
RNA isolation kit (Macherey-Nagel, Dueren, Germany). The RNA was treated with DNAse-I 
(Macherey-Nagel) and reverse-transcribed using a High-Capacity complementary DNA (cDNA) 
Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). Specific Hmox2, Hamp, Hrg1, 
and HFt fragments were then PCR amplified from this cDNA using the specific primers (Table S3, 
Supplementary Materials). As a control, primers amplifying the housekeeping beta actin gene (Actb) 
were used. For RT-qPCR analysis, standard curves were generated using serial dilutions of cDNA 
to determine the amplification efficiency of each primer pair. To evaluate the relative expression
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level compared to Actb, the 2-AAct method was used. Real-time PCR was performed with the 
Power SybrGreen quantitative PCR kit (Applied Biosystems) using a StepOne thermocycler (Applied 
Biosystems, Foster City, CA, USA).
4.10. Prussian Blue Staining o f Kidney
Non-heme iron staining of kidney samples was analyzed using Accustain Iron Deposition 
Kit (Sigma-Aldrich, Saint Louis, MO, USA). Kidneys were dissected, immediately fixed in Bouin's 
solution for 24 h, and stored in 70% ethanol before further preparation. After dehydration, samples 
were embedded in paraffin and cut into 7 pm sections with a microtome (Reichert-Jung, Nussloch, 
Germany). After mounting on glass slides, sections were deparaffinized, incubated with working 
solution containing Perls' Prussian Blue for 30 min, counterstained with pararosaniline solution for 
2 min, and analyzed under standard light microscopy on Olympus CH2 and Nikon Eclipse E600 
microscopes (Nikon Instruments, Amsterdam, The Netherlands).
4.11. Statistical Analysis
Datasets were analyzed for normal distribution using the Shapiro-Wilk test. Differences between 
wild-type and HO1 knockout mice in each age group were compared by parametric, two-tailed, 
Student's t-test for data with normal distribution and nonparametric, M ann-W hitney U test for 
data where distribution was not normal. A p-value <0.05 was considered statistically significant. 
For statistical analyses and graph preparation, we used Graph Pad Prism 5 (GraphPad Software, San 
Diego, CA, USA) and STATISTICA 13 software (StatSoft, Krakow, Poland)
Supplementary Materials: The following are available online at http://www.mdpi.com/1422-0067/21/20/7754/s1, 
Table S1: Antibodies used in immunoblotting; Table S2: Antibodies used in immunofluorescence analysis; Table S3: 
Primers used in real-time PCR analysis.
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